PDCD1 and metastatic melanoma: In a further study, thousands of immune cells from 48 tumor samples of melanoma patients were analyzed using single-cell gene expression profiles of lesional immune cells from metastatic melanomas under ICI (predominantly anti-PD-1) treatment [29].